Evidence map›Paper›PMID 34490229›Full record

ReviewFrontiers in bioengineering and biotechnology2021

Therapeutic Applications of Metal and Metal-Oxide Nanoparticles: Dermato-Cosmetic Perspectives.

Sharadwata Pan, Thomas B Goudoulas, Jaison Jeevanandam, Kei Xian Tan, Shamik Chowdhury, Michael K Danquah

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Physical properties and pharmacological applications of CoWorld journal of microbiology & biotechnology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Sharadwata PanTUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Thomas B GoudoulasTUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Jaison JeevanandamCQM-Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, Funchal, Portugal.
Kei Xian TanSchool of Materials Science and Engineering, Nanyang Technological University, Nanyang, Singapore.
Shamik ChowdhurySchool of Environmental Science and Engineering, Indian Institute of Technology Kharagpur, Kharagpur, India.
Michael K DanquahDepartment of Chemical Engineering, University of Tennessee, Chattanooga, TN, United States.
Technical University of Munich · DEIndian Institute of Technology Kharagpur · INNanyang Technological University · SGUniversidade da Madeira · PTUniversity of Tennessee at Chattanooga · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invention of novel nanomaterials guaranteeing enhanced biomedical performance in diagnostics and therapeutics, is a perpetual initiative. In this regard, the upsurge and widespread usage of nanoparticles is a ubiquitous phenomenon, focusing predominantly on the application of submicroscopic (< 100 nm) particles. While this is facilitated attributing to their wide range of benefits, a major challenge is to create and maintain a balance, by alleviating the associated toxicity levels. In this minireview, we collate and discuss particularly recent advancements in therapeutic applications of metal and metal oxide nanoparticles in skin and cosmetic applications. On the one hand, we outline the dermatological intrusions, including applications in wound healing. On the other hand, we keep track of the recent trends in the development of cosmeceuticals

Indexed as

cosmeticsdermalmetalmetal oxidenanoparticlerheologytherapeutic

Identifiers

PMID34490229
PMCPMC8417693
OpenAlexW3193520696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.